News Headlines Article

3 Drugs for an Eye Disease, With Big Price Gaps, Are Found to Be Equals for Many
New York Times

At a time of rising concern over the cost of medicine, a government-funded study has found that three drugs, ranging in price from $50 to $1,950 a dose, are equally effective in treating many cases of a common form of vision loss caused by diabetes.

But the most expensive drug — Eylea, sold by Regeneron Pharmaceuticals — was more effective for patients who had poorer vision before starting treatment.